Two new medications, called lecanemab and donanemab, have shown success in clinical trials in slowing down Alzheimer’s disease. These are known as disease-modifying treatments. One of these, lecanemab ...

Brad Axis Brain and Back Institute +1 (817) 502-7411 ... Visit us on social media: Facebook X LinkedIn YouTube ...

Diabetes UK has warned that the UK is in the grip of a 'rapidly escalating crisis' as the number of diagnosed diabetes cases ...

Jiangsu Alicorn Pharmaceutical Co. Ltd. has described AP2-associated protein kinase 1 (AAK1) inhibitors reported to be useful for the treatment of Alzheimer’s disease, bipolar disorder, Parkinson’s ...

Nevro Corp. , a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced the publication of new data in the Journal of ...

Over the past decade of being a podiatrist, I have performed hundreds–if not thousands–of amputations in the foot, or had to ...

AstraZeneca and Ionis' drug Wainzua (eplontersen) has been recommended for approval in the European Union for treating ...

Clinicians are hopeful the new approach will give people with aggressive cervical cancer additional options for treatment, particularly those who face barriers to healthcare. Cervical cancer ...

SINGAPORE – Newer drugs within a class originally developed to treat diabetes are now gaining attention as potential treatments for ... with six new cases diagnosed every day.

This form of neuropathy carries a high risk of pain, trophic changes and autonomic dysfunction. There is currently no effective treatment for diabetic neuropathy, and good glycemic control is the ...

Uncontrolled diabetes can affect the nerves and lead to a condition called diabetic neuropathy. The most common type of nerve damage occurs in ... resulting in delayed diagnosis and treatment and ...

Now, scientists have made a major breakthrough in developing what has been long called the “holy grail” diabetes treatments — a “smart” insulin that responds in real time to fluctuations in one’s ...